Jupiter NeurosciencesJUNS
13F holders, Q1 2025 (March 31)7holders +4
5new positions
1sold out
$0.61avg. 13F price*
At the end of Q1 2025, 7 institutions reported holding Jupiter Neurosciences Inc. (JUNS) in their 13F filings, up 4 from Q4 2024. 5 opened new positions and 1 sold out. The largest holders were UBS Group AG ($83K), Citigroup Inc. ($68K) and Two Sigma Securities, LLC ($42K).
- Company
- Jupiter Neurosciences Inc.
- CUSIP
- 48208B203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $79K |
| Exits | 1 | $6K |
All 13F filers, Q4 2024 → Q1 2025: 373,460 shares bought and 561 shares sold, net +372,899 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| UBS Group AG | 0.00% | Add +542460.0% | 135,640 | $83K |
| Citigroup Inc. | 0.00% | Add +2393.9% | 111,977 | $68K |
| Two Sigma Securities, LLC | 0.01% | New | 68,424 | $42K |
| Two Sigma Investments, LP | 0.00% | New | 21,761 | $13K |
| HRT Financial LP | 0.00% | New | 14,848 | $9K |
| BlackRock, Inc. | 0.00% | New | 12,720 | $8K |
| Qube Research & Technologies Ltd | 0.00% | New | 12,605 | $8K |
"% of holder's portfolio" is JUNS's weight in each manager's 13F, not the share of Jupiter Neurosciences Inc. the manager owns.